ðŸð± ç¬ç«ãã¥ãŒã¹ â 2026.07.27
ç¬4 ïŒ ç«2 ïŒ èš6ä»¶
ðŸ ç¬ãã¥ãŒã¹ â 2026.07.27
æ¬æ¥ 4ä»¶
1. ð¥ å»çã»çŸç ã»äºé²
ãã©ã€ã ç ïŒã¬ããã¹ãã©ãã1æ¬ã®ã¯ã¯ãã³ã§ââUSDAãåé0.5mLã®æ°åã³ã³ããTruCan Ultra Lyme-L4ããæ¿èª
ð 2026.06.15
ãšã©ã³ã³ã»ã¢ããã«ãã«ã¹ã¯2026幎6æ15æ¥ãç¬ã®ã©ã€ã ç ãšã¬ããã¹ãã©çã1åã®æ¥çš®ã§äºé²ã§ããæ°ããæ··åã¯ã¯ãã³ãTruCan Ultra Lyme-L4ããUSDAïŒç±³èŸ²åçïŒã®æ¿èªãåŸããšçºè¡šãããç¹åŸŽã¯æ¥çš®éãããã0.5mLãšåŸæ¥åïŒ1mLïŒã®ååã«æããããŠããç¹ã§ãåãç¯å²ã®é²åŸ¡åãä¿ã¡ãªããäœãžã®è² æ ãæžãããã©ã€ã ç ã¯ããããåªä»ããã¬ããã¹ãã©çã¯ææåç©ã®å°¿ã§æ±æãããæ°Žãåããææãã人ç£å ±éææçã§ãããããè¿å¹Žãæž©æåãªã©ãèæ¯ã«æµè¡åãæ¡å€§ããŠããããšã©ã³ã³ç¬èªã®ãPureFilæè¡ãã§äžèŠãªã¿ã³ãã¯è³ªãåãé€ããæ¥çš®åŸã®å¯åå¿ãæžããèšèšã ãšãããçºå£²ã¯çºè¡šããçŽ30æ¥ä»¥å ã«å§ãŸãèŠèŸŒã¿ã ã
ç¬ã®ã¯ã¯ãã³ã¯çš®é¡ãå¢ããã»ã©1åã®éé¢ã§è€æ°æ¬ã®æ³šå°ãå¿ èŠã«ãªãã飌ãäž»ã«ãç¬ã«ãã¹ãã¬ã¹ããããã2çš®ã1æ¬ã«ãŸãšãããããéãååã«ã§ããã°ã泚å°ã®çã¿ãå¯åå¿ã®ãªã¹ã¯ãæãã€ã€å¿ èŠãªäºé²ãã«ããŒãããããªããã©ã€ã ç ãã¬ããã¹ãã©çããçºçãããšé¢ç¯çãè é害ã»èé害ãªã©éãçç¶ã«ã€ãªããããšããããäºé²ã®æçŸ©ã¯å€§ããããã ãã©ã€ã ç ã¯ã¯ãã³ã¯ãã¹ãŠã®ç¬ã«äžåŸã§æšå¥šãããããã§ã¯ãªããå± äœå°åã®ãããã®å€ããçæŽ»ã¹ã¿ã€ã«ã«ãã£ãŠå¿ èŠæ§ãå€ãããæ¥æ¬åœå ã§ã®çºå£²ã¯æªå®ã ããæç¬ã«ã©ã®ã¯ã¯ãã³ãé©åãã¯ããããã€ãã®ç£å»åž«ãšçžè«ããŠæ±ºããŠã»ããã
ð https://www.dvm360.com/view/usda-approves-canine-vaccination-for-lyme-disease-and-leptospirosis
ð·ïž å»çã»çŸç ã»äºé²
2. ð¥ å»çã»çŸç ã»äºé²
åç¬ããèç¬ãŸã§ãåããšçã¿ããäžžããšèšæž¬ââã«ã«ã¬ãªãŒå€§ãç¬ã®å¥åº·ãè¿œãæ°ã©ããéèš
ð 2026.07.22
ã«ããã®ã«ã«ã¬ãªãŒå€§åŠç£å»åŠéšã¯2026幎7æãç¬ã®çã¿ãéååšïŒçéªšæ Œç³»ïŒã®äžèª¿ãæ©æã«èŠã€ããçæ¶¯ã«ããã£ãŠå¥åº·ãå®ãããšãç®æããCanine Performance LabïŒç¬ããã©ãŒãã³ã¹ç ç©¶æïŒãã®éèšãçºè¡šããããããããŒã倧æãã£ã³ããªã³ã»ãããããŒãºããçŽ113.5äžã«ãããã«ã®æè³ãåãã倧åŠã®ç£å»åŠéšãšå°åã®åç©ãŠã§ã«ãã¹æœèšã飿ºãããææ°ã®ã¢ãŒã·ã§ã³ãã£ããã£ãŒãã»ã³ãµãŒã§ç¬ã®æ©ãæ¹ãåäœã客芳çã«èšæž¬ããåç¬ããèç¬ãŸã§ãå¥åº·ãªç¬ã»æŽåœ¢å€ç§çŸæ£ãæã€ç¬ã»ç¬çš®ãçšéã®ç°ãªãç¬ãå¹ åºã远跡ããèšç»ã ãåŠéšé·ã®ã¬ããŒãã»ãŠã§ã©ãŒæ°ã¯ãåãã»çã¿ã»ç掻ã®è³ªã»æ é€ã»éåã®é¢ä¿ããåéãè¶ ããŠç·åçã«èŠãããšèª¬æããã
ç¬ã¯çã¿ãèšèã§èšŽãããããæ¬èœçã«äžèª¿ãé ããããå€åœ¢æ§é¢ç¯çãªã©ã®éååšã®åé¡ã¯æ°ã¥ãããšãã«ã¯ããªãé²ãã§ããããšãå€ããæ©æ§ãæ°å€ã§æããæè¡ãæ®åããã°ã飌ãäž»ãç£å»åž«ãããªããšãªãå æ°ããªããã客芳çãªããŒã¿ãšããŠæ©æã«ãã£ããããäœé管çãéåã»æ²»çã®ä»å ¥ãæ©ãå§ããããå¯èœæ§ãããããšãã«ã·ãã¢ç¬ã®QOLïŒç掻ã®è³ªïŒç¶æã«ã¯ãçã¿ã®æ©æçºèŠãæ¬ ãããªããæ¥ã ã®æ£æ©ã§æç¬ã®æ©ãæ¹ãç«ã¡äžããæ¹ã®å€åã«æ°ã¥ããããæ§åèŠããç£å»åž«ã«çžè«ããããšããããããç ç©¶ã®ææãåŸ ã€ããã ã«ãã§ããæåã®äžæã ã
ð·ïž å»çã»çŸç ã»äºé²
3. 𧬠ç ç©¶ã»ç§åŠ
ç¬ã¯èªéçç ç©¶ã®ãæå€ãªå³æ¹ãã«ãªãããââéºäŒåæ¹å€ããŒã°ã«ã䜿ãã¢ãã«ãæå±ããç·èª¬
ð 2026.06.24
Genomic Psychiatryèªã«2026幎6æ24æ¥ä»ã§çºè¡šãããç·èª¬ïŒããŒã¹ãã¯ãã£ãïŒã§ãç ç©¶è ãã¯ç¬ããšãã«éºäŒåæ¹å€ããããŒã°ã«ããèªéã¹ãã¯ãã©ã çïŒASDïŒã®æ°ããç ç©¶ã¢ãã«ãšããŠæŽ»çšã§ããã®ã§ã¯ãªãããšææ¡ãããèæ¯ã«ã¯ããããŸã§30幎ã«ãããèªéçã®åè£æ²»çè¬ã®9å²ä»¥äžããåç©å®éšãã人ã®èšåºè©Šéšãžé²ã段éã§å€±æããŠãããšããå³ããçŸå®ããããããŠã¹ãªã©ã®å®éšåç©ã¯ãèªéçã§æãæãªããããç®ãèŠäº€ãããããªè±ããªç€ŸäŒçã³ãã¥ãã±ãŒã·ã§ã³ããåçŸã§ããªãããã ãç¬ã¯ããã3äžå¹ŽããããŠäººãšå ±ã«é²åãã人ã«è¿ã瀟äŒçèªç¥ãçºéãããŠããç¹ã泚ç®ãããŠããã
ç¬ãã¢ãã«ã«ããæ§æ³ã«ã¯å€§ããªèª²é¡ãæ®ããè«æã®èè ãããç¬ã§ã®éºäŒåç·šéã¯ãŸã æåçã4åã®1çšåºŠã«ãšã©ãŸããè³ã¹ãã£ã³ã®ããã«ãã£ãšããŠããããããèšç·Žããã«ã¯2幎è¿ããããããšãèªããŠãããããã§ãã人ãšç€ŸäŒæ§ãå ±æããåç©ã§ããç ç©¶ã§ããããšããããšããçºæ³ã¯ãåç©çŠç¥ã«é æ ®ãã€ã€æ°ããæ²»çæ³ã®ç³žå£ãæ¢ã詊ã¿ãšããŠè峿·±ããããã¯ãããŸã§ç ç©¶ã®æ¹åæ§ã瀺ãæèšã§ãããããã«ç¬ã§èªéçæ²»çè¬ã詊éšãããããã§ã¯ãªããæç¬å®¶ãšããŠã¯ãç¬ãšããååšã人ã®å»çã®çºå±ã«ãè²¢ç®ããããšããèŠç¹ãç¥ã£ãŠãããšãæ¯èŒå»åŠïŒäººãšåç©ã®ç æ°ãæ©æž¡ãããç ç©¶ïŒã®ãã¥ãŒã¹ããã身è¿ã«æããããã ããã
ð https://www.eurekalert.org/news-releases/1133232
4. ðïž ãã¬ãŒãã³ã°ã»è¡åç§åŠ
CBDãé·ãäžããŠããç¬ã¯ãæ»ææ§ããäœãåŸåââ47,355é ã®å€§èŠæš¡ããŒã¿ã瀺ããæå€ãªé¢é£
ð 2025.11.28
ç±³åœã®ç¬47,355é ã®ããŒã¿ãè§£æããç ç©¶ããCBDïŒã«ã³ãããžãªãŒã«ïŒãé·æçã«äžããããŠããç¬ã§ã¯æ»æçãªè¡åãå°ãªãåŸåã«ãããšå ±åããFrontiers in Veterinary Scienceèªã«æ²èŒããããCBDãäžããããŠããç¬ã¯å šäœã®7.3%ã§ããã¡5.8%ã¯æ¯æ¥æåããŠãããããããç¬ã¯å¹³åããŠä»ã®ç¬ããçŽ3æ³å¹Žäžã§ãèªç¥çïŒ18%ïŒãé¢ç¯ã®åé¡ïŒ13%ïŒãããïŒ10%ïŒãæ±ããŠããå²åãé«ãã£ããæ»ææ§ã®äœäžãšããåŸåã¯ã倧麻ã«å¯å®¹ãªå·ã«äœã飌ãäž»ã®ç¬ã§ãšãã«åŒ·ãèŠããããšãããäžæ¹ã§ãäžå®ã«é¢ãããã®ä»ã®è¡åã«ã¯æç¢ºãªæ¹åã¯èŠãããªãã£ãã
ãã®ç ç©¶ã¯ãããŸã§å€§èŠæš¡ãªèгå¯ããŒã¿ã®ãé¢é£ãã瀺ãããã®ã§ãCBDãæ»ææ§ãäžãããšå æé¢ä¿ã蚌æããããã§ã¯ãªãç¹ã«æ³šæãå¿ èŠã ã幎霢ãæç ãªã©ãæ»ææ§ã«åœ±é¿ããä»ã®èŠå ã絡ãã§ããå¯èœæ§ãåŠå®ã§ããªããç ç©¶è ãããCBDã¯äžèœè¬ã§ã¯ãªããé©åãªãã¬ãŒãã³ã°ããããªãç ç©¶ãè£ããã®ã ããšåŒ·èª¿ããŠãããCBD補åã¯åè³ªãæ¿åºŠã«ã°ãã€ãã倧ãããä»ã®è¬ãšã®çžäºäœçšãå ±åãããŠãããæç¬ã«ãµããªãšããŠäžããããšãæ€èšããå Žåã¯ãèªå·±å€æã§å§ãããå¿ ãç£å»åž«ã«çžè«ããŠã»ããã
ð https://www.sciencedaily.com/releases/2025/11/251128050506.htm
ð·ïž ãã¬ãŒãã³ã°ã»è¡åç§åŠ
ð¡ 仿¥ã®ã¯ã³ãã€ã³ãïŒä»æ¥ã®ãã¥ãŒã¹ã¯ãäºé²ããšãæ©æçºèŠããããŒã¯ãŒããã¯ã¯ãã³ããæ©ãæ¹ã®å€åããæ»ææ§ã®èæ¯ã«ããçã¿ãäžèª¿ããæ©ãæ°ã¥ããŠæãæã€ã»ã©æç¬ã®è² æ ã¯å°ãããªããè¿·ã£ãããæ§åèŠãããããŸãç£å»åž«ã«çžè«ããã
ð± ç«ãã¥ãŒã¹ â 2026.07.27
æ¬æ¥ 2ä»¶
1. ð¥ å»çã»çŸç ã»äºé²
ç«ã®ãé³¥ã€ã³ãã«ãšã³ã¶ïŒH5N1ïŒããç£èŠããââã³ãŒãã«å€§ãã·ã§ã«ã¿ãŒç«ãå€§èŠæš¡èª¿æ»ãèŽæ»çã¯æå€§7å²ãšã®å ±åã
ð 2026.07.01
ç«ã®é³¥ã€ã³ãã«ãšã³ã¶ïŒé«ç åæ§é³¥ã€ã³ãã«H5N1ïŒãžã®ææãè¿å¹Žæ¥å¢ããŠãããšããŠãã³ãŒãã«å€§åŠç«å¥åº·ã»ã³ã¿ãŒãäž»å°ãããç«ãŠã€ã«ã¹ãµãŒãã€ã©ã³ã¹ã»ã³ã³ãœãŒã·ã¢ã ãããç±³ãã¥ãŒãšãŒã¯å·ã®ã·ã§ã«ã¿ãŒãå°åã®é¿åŠå»å¢ã¯ãªããã¯ã§å€æ°ã®ç«ã察象ã«ãã調æ»ãå§ããïŒAmerican Journal of Veterinary Research 2026幎 第87å·»7å·ã»ãïŒãç®çã¯ãå°åç«ã«ãããçŸåšã®ææç¶æ³ã®ææ¡ãéå»ã®H5N1æé²ã®è¡æž åŠç蚌æ ã®è©äŸ¡ããããŠãŠã€ã«ã¹ã®ã²ãã è§£æã ãç«ã¯é ªèŸ²å Žã§å ç±ããŠããªãçä¹³ãä»ããŠããããã¯å®¶åºã§ã¯é³¥ç±æ¥ã®çèããŒããéé³¥ãšã®æ¥è§ŠãéããŠææãããšã¿ãããéçã®è³çãèµ·ãããäŸãå ±åãããŠãããææç«ã®èŽæ»çã¯æå€§70%ã«éãããšã®å ±åãããã
ã¡ãªãŒã©ã³ã倧åŠã®å ¬è¡è¡çç ç©¶è ãã¯ãç«ã®H5N1ææããåããã¹ã泚ç®ãåããŠããªãããšèŠåããç£èŠã®åŒ·åã蚎ããŠãããç«ã¯ã€ã³ãã«ãšã³ã¶ã®çæ ãé²åã«ãããŠéèŠã ãèŠéããããŠããååšã§ã人ãžã®ææã®æ©æž¡ã圹ã«ãªãæžå¿µãããïŒå®éãææç«ã«æ¥è§Šããç£å»çåŸäºè ã®è¡æž ããæäœãæ€åºãããäŸãç±³åœã§å ±åãããŠããïŒã飌ãäž»ã«ã§ããäºé²ã¯çŸå®çã ãå ç±ããŠããªãçèã»çä¹³ã¿ã€ãã®ããŒãã¯é¿ããå®å šå®€å 飌ããåºæ¬ãšããéé³¥ããã®æ»éªžã«è¿ã¥ããªãããšãããæç«ã«çºç±ã»åŒåžåšçç¶ã»ç¥çµçç¶ãåºãããé³¥ã€ã³ãã«ã®å¯èœæ§ã念é ã«ãæ©ãã«ç£å»åž«ãžçžè«ããŠã»ããã
ð https://avmajournals.avma.org/view/journals/ajvr/87/7/ajvr.26.05.0208.xml
ð·ïž å»çã»çŸç ã»äºé²
2. ð¥ å»çã»çŸç ã»äºé²
ãã¯ã¯ãã³ã¯å¥åº·ã®æ±ããšèãã飌ãäž»ã¯ããã16%ââç£å»åž«ãšã®âæèã®ãºã¬âãæµ®ã圫ãã«
ð 2026.07.20
ã¡ã«ã¯ã»ã¢ããã«ãã«ã¹ã¯2026幎7æ20æ¥ãç«ã®é£Œãäž»ãšç£å»åž«ã察象ã«ããäžççãªèª¿æ»çµæãçºè¡šãããããã«ãããšãç«ã®å¥åº·ç¶æã«éèŠãªèŠçŽ ãšããŠãã¯ã¯ãã³æ¥çš®ããæãã飌ãäž»ã¯ããã16%ã ã£ãã®ã«å¯Ÿããç£å»åž«ã§ã¯69%ãšãäž¡è ã®èªèã«å€§ããªéããããã£ãã飌ãäž»ãæããå¥åº·ã®èŠçŽ ã¯é«å質ãªé£äºïŒ94%ïŒãæå€ã§ã以äžãåç©ç é¢ã§ã®å¥åº·èšºæïŒ39%ïŒãææ ïŒ35%ïŒãéã³ïŒ17%ïŒãšç¶ããã¯ã¯ãã³ã¯æäžäœã ã£ããã¯ã¯ãã³ãæããªãçç±ãšããŠã¯ãå¥åº·ãªç«ã«ã¯äžèŠãã宀å 飌ãã ããäžèŠãïŒãããã27%ïŒãç®ç«ã£ããäžæ¹ã§ãã¯ã¯ãã³ãæ¥çš®ãã飌ãäž»ã®57%ã¯ãç£å»åž«ã®æšå¥šããæ±ºãæã«æããŠããã
ãã®çµæã¯ãç«ã®ã¯ã¯ãã³æ¥çš®çãäžããéµããç£å»åž«ãã飌ãäž»ãžã®ãæ å ±å ±æãã«ããããšã瀺ããŠãããå®éã飌ãäž»ã®58%ãç£å»åž«ãäž»ãªã¯ã¯ãã³æ å ±æºãšããŠããã®ã«ãæè²çãªè³æãå®éã«é£Œãäž»ãžæž¡ããŠãããšçããç£å»åž«ã¯23%ã«ãšã©ãŸã£ãã宀å 飌ãã§ãã人ãå€ããæã¡èŸŒããŠã€ã«ã¹ããè±èµ°ã»çœå®³æã®äºæãã¬å€åºã§ææãªã¹ã¯ã¯ãŒãã«ãªããªããã©ã®ã¯ã¯ãã³ããã³ã¢ïŒå¿ é ïŒãã§ãã©ããçæŽ»ç°å¢ã«å¿ããããã³ã³ã¢ããªã®ãã¯ç«ããšã«ç°ãªããæç«ã«ãšã£ãŠæ¬åœã«å¿ èŠãªäºé²ã¯äœããæ¬¡ã®å¥åº·èšºæã®ãšãã«ãããã€ãã®ç£å»åž«ã«é æ ®ãªãå°ããŠã¿ãŠã»ããã
ð·ïž å»çã»çŸç ã»äºé²
ð¡ 仿¥ã®ã¯ã³ãã€ã³ãïŒç«ã¯äžèª¿ãæ°æã¡ãé ãã®ãåŸæãé³¥ã€ã³ãã«ã«ããã¯ã¯ãã³ã«ãããã宀å 飌ãã ãã倧äžå€«ããšããæã蟌ã¿ãç²ç¹ã«ãªãããããçèããŒãã®ãªã¹ã¯ãæ¬åœã«å¿ èŠãªäºé²ã«ã€ããŠãç£å»åž«ãšäžåºŠãã£ãã話ããŠãããã
æ¯æ7æé ä¿¡

ã³ã¡ã³ããæ®ã